Anthony GONCALVES, MD
Institut Paoli-Calmettes
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Anthony GONCALVES, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:52 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT05143970 · A Phase 1 First-In-Human Study of the Anti-CD73 IPH5301 Alone or in Combination With Chemotherapy and Trastuzumab in Patients With Advanced Solid TumorsInstitut Paoli-Calmettes · active not recruiting · Metastatic Cancer, Metastatic Breast Cancer, Metastatic Pancreatic Cancer · principal investigator
- Ph1/Ph2NCT01980277 · Phase Ib/II Study of LY2780301 in Combination With Weekly PACLITAXEL in HER2-metastatic Breast CancerInstitut Paoli-Calmettes · terminated · Breast Cancer · principal investigator
- Ph1/Ph2NCT01589861 · Safety and Efficacy of BKM120 and Lapatinib in HER2+/PI3K-activated, Trastuzumab-resistant Advanced Breast CancerInstitut Paoli-Calmettes · terminated · Breast Cancer · principal investigator
- Ph1NCT00908869 · Combination of Continuous Low Doses of Vinorelbine, Cyclophosphamide and Interferon Alpha 2b (" Metronomic Chemotherapy ") for Antiangiogenic and Antivascular Effect. Trial With Pharmacodynamic Study in Adult Advanced NeoplasmInstitut Paoli-Calmettes · completed · Advanced Neoplasm · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:52 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in breast cancer.